InvestLog
RAPP Rapport Therapeutics, Inc. Common Stock logo

RAPP Rapport Therapeutics, Inc. Common Stock

Healthcare
$39.71+5.28%ClosedMarket Cap: $1.45B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

0

Dispositions

9

Buy/Sell Ratio

0.00

Net Shares

-876,586

Shares Acquired

0

Shares Disposed

876,586

Total Bought ($)

$0.00

Total Sold ($)

$9.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 13Third Rock Ventures V, L.P.10 percent ownerSell133,618$40.246,299,097
Mon May 11Third Rock Ventures V, L.P.10 percent ownerSell271,495$40.126,437,733
Mon May 11Third Rock Ventures V, L.P.10 percent ownerSell5,018$40.316,432,715
Tue Apr 21Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell20,225$39.99246,426
Tue Apr 21Third Rock Ventures V, L.P.10 percent ownerSell426,005$40.326,709,228
Tue Apr 14Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell10,200$35.08266,651
Tue Apr 14Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell9,165$34.97276,851
Tue Apr 14Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell500$34.98286,016
Thu Apr 09Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell360$34.90286,516
Tue Mar 31Gault Cherylofficer: Chief Operating OfficerSell7,161$28.04162,753
Tue Mar 31Gault Cherylofficer: Chief Operating OfficerSell2,839$28.55159,914
Thu Mar 26Yeleswaram Krishnaswamyofficer: Chief Development OfficerSell10,115$29.99286,876
Mon Mar 09Gault Cherylofficer: Chief Operating OfficerSell2,014$28.93169,914
Thu Feb 19Ceesay Abrahamdirector, officer: Chief Executive OfficerSell3,552$29.05558,528
Thu Feb 19Ceesay Abrahamdirector, officer: Chief Executive OfficerSell2,983$29.0422,829